Implantable Drug Delivery Devices Market was valued at USD 760 million and is expected to grow at a CAGR of 21.3% from 2013 to 2019 to reach an estimated value of USD 2,937.3 million by 2019.
Browse the full report at http://www.transparencymarketresearch.com/implantable-drug-delivery-devices.html
Implantable drug delivery devices hold a competitive edge over other drugs and devices owing to the fact that they are implanted at targeted sites and so deliver unaltered amounts of drugs to the affected area. These implantable drug delivery devices are categorized into six product types and this report estimates their market in terms of USD million, for the period 2012 - 2018, keeping 2011 as the base year.
The market is segmented on the basis of product types into implantable infusion pumps, brachytherapy seeds, contraceptive implants, drug eluting stents, bio-absorbable stents and intraocular drug delivery implants. The market for all these product segments is provided in this report for four major geographic regions namely North America, Europe, Asia and the rest of the world regions (RoW). The market is segmented on the basis of technology into biodegradable and non-biodegradable implant technology and on the basis of applications into oncology, cardiovascular, contraceptive, ophthalmology and others (diabetes, inflammatory conditions).
A competitive landscape, mapping all the market players and their respective market shares for 2011 are provided in this report along with some major business strategies adopted by these players to accentuate market shares. A chapter on recommendations for existing and new entrants is also provided.
Some of the major players profiled in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Implantable Drug Delivery Devices Market, By Product Types
5 Global Implantable Drug Delivery Devices Market, By Technology
6 Global Implantable Drug Delivery Devices Market, By Applications
7 Implantable Drug Delivery Devices Market By Geography
9 Competitive Landscape
10 Company Profiles
- Abbott Laboratories
- Allergan, Inc.
- Bausch & Lomb Inc.
- Bayer Healthcare
- Boston Scientific Corporation
- Medtronic Inc.
- Psivida Corp.
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.